A new international consortium to promote Stem Cell-Based Therapy for Huntington's disease
The Stem Cells for Huntington's Disease (SC4HD) is a new international consortium created to promote advanced therapy medicinal product (ATMP) thro...
The Stem Cells for Huntington's Disease (SC4HD) is a new international consortium created to promote advanced therapy medicinal product (ATMP) thro...
Hospital Clínic participated in a study which shows that the implantation of pacemakers and defibrillators has dropped by more than 50% during...
Researchers from IDIBAPS and CIBERONC have analysed the interaction between follicular lymphoma and its tumour microenvironment and propose a new p...
A new study led by researchers at Hospital Clínic-IDIBAPS and the Pompeu Fabra University provides the largest catalogue to date of postnatal molec...
A study by IDIBAPS-CSIC has identified a mechanism that favors the accumulation of the accumulation of defective mitochondria found in diseases suc...
In a study published in the Journal of Clinical Oncology, researchers from the Hospital Clínic-IDIBAPS-UB and SOLTI showed the predictive capacity...
This methodology makes it possible to determine the risk of developing these diseases before symptoms appear in people with REM sleep behavior diso...
An article published in the journal Nature suggests that immunotherapy is effective in patients with HCC of viral origin but does not increase surv...
A study carried out at Hospital Clínic of Barcelona analysed the outcomes of patients with autoimmune disease and COVID-19 infection who were admit...
The journal Autophagy has published the 4th edition of an international consensus document on the interpretation, mechanisms, and different multidi...